When was Cleerly founded?

Cleerly was founded in 2016 and raised its 1st funding round 4 years after it was founded.

Where is Cleerly located?

Cleerly is headquartered in Denver, United States. It is registered at 1099 18TH ST STE 2860,DENVER,CO,80202,0.

Who is the current CEO of Cleerly?

James Min of Cleerly. They have also founded 1 company.

How many employees does Cleerly have?

As of Jun 30, 2026, the latest employee count at Cleerly is 359.

Is Cleerly a funded company?

Cleerly is a funded company, having raised a total of $578M across 5 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Apr 03, 2020.

When was the latest funding round of Cleerly?

Cleerly's latest funding was a $***** Series C round on Nov 19, 2024, with participation from 2 investors.

Where does Cleerly rank among its competitors?

Cleerly ranks 9th amongst 750 active competitors, of which 165 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Carpl, which secured $10M in Jul, 2026.

Who are the top competitors of Cleerly?

Cleerly's top competitors include Qure.ai, HeartFlow and AIdoc. Among them, Carpl secured the most recent funding round in July, 2026.

Cleerly - 2026 Company Profile, Team, Funding & Competitors

Cleerly is a series C company based in Denver (United States), founded in 2016 by James Min. It operates as a Provider of an AI-driven platform for coronary artery disease assessment. Cleerly has raised $578M in funding from investors like Fidelity Investments, T. Rowe Price and Insight Partners. The company has 750 active competitors, including 165 funded and 45 that have exited. Its top competitors include companies like Qure.ai, HeartFlow and AIdoc.

Company Details

Provider of an AI-driven platform for coronary artery disease assessment. The platform quantifies atherosclerosis by measuring plaque volume, composition, length, and location. It evaluates stenosis severity and determines the likely presence or absence of ischemia. The software aims to reduce the need for additional testing and enhance diagnostic confidence.

Website: cleerlyhealth.com
Social
Email ID: *****@cleerlyhealth.com
Registered Address: 1099 18TH ST STE 2860,DENVER,CO,80202,0

Key Metrics

Founded Year

2016

Location

Denver, United States

Stage

Series C

Total Funding

$578M in 5 rounds

Latest Funding Round

Series C, Nov 19, 2024, $*****

Investors

Fidelity Investments & 21 more

Ranked

9^th among 750 active competitors

Employee Count

359 as on Jun 30, 2026

Similar Companies

OpenEvidence & 3104 more

View Cleerly's full profile

Cleerly is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Cleerly, Inc. CIN: 32088369080 , United States, Active	Feb 09, 2023	-	-	-

Cleerly has raised a total funding of $578M over 5 rounds. Its first funding round was on Apr 03, 2020. Its latest funding round was a Series C round on Nov 19, 2024 for $*****. 2 investors participated in its latest round. Cleerly has 20 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Cleerly:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 19, 2024	9877144	Series C	6162318	8217921	5981280	3639866
Aug 30, 2022	8513242	Series C	9353180	3546198	4057812	Piper Sandler & 11 more
Mar 11, 2022	3379947	Series C	1305922	7719520	T. Rowe Price & 1 more	Piper Sandler & 10 more

Access funding benchmarks and valuations. Sign up today!

View details of Cleerly's funding rounds and investors

The founders of Cleerly is James Min. James Min is the CEO of Cleerly.

Here are the details of Cleerly's key team members:

James Min: Founder & CEO of Cleerly.

Cleerly's Board of Directors

Cleerly's board has 16 active members. Lee Cooper, Scott Barclay, Vijay Lathi, Roy Beveridge, Peter Justin Klein, James Earls, James K. Min, Louis Samson, Nick Nieslanik, Word D. Peake III, Oscar Munoz, Kristin Binns, Glenn Steele, Word D. Peake, Jim Hartman and Kevin King are independent board members.

Here is the list of Cleerly's board of directors:

Name	Type	Representing	Status	Duration
Lee Cooper	Independent board member	-	Current	1y 9m
khpmse{	Independent board member	-	Current	1y 4m
buodhoo	Independent board member	-	Current	9y 7m
bdieic{	Independent board member	-	Current	7y 6m
wjfdgud	Independent board member	-	Current	9y 6m
guneutf	Independent board member	-	Current	8y 1m
{xygkpu	Independent board member	-	Current	5y 6m
jbdbudi	Independent board member	-	Current	6y 3m
jlmduft	Independent board member	-	Current	6y 5m
dnvhdtb	Independent board member	-	Current	6y 3m
kgansxj	Independent board member	-	Current	6y 5m
mexn{rp	Independent board member	-	Current	8y 3m
u{kxdfj	Independent board member	-	Current	2y 1m
kfisjnp	Independent board member	-	Current	8y 3m
onzgufv	Independent board member	-	Current	1y 4m
pocxdub	Independent board member	-	Current	3y 6m

View details of Cleerly's Founder profiles and Board Members

Cleerly's employee count trend

Cleerly has 359 employees as of Jun 26. Here is Cleerly's employee count trend over the years:

Uncover Cleerly's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cleerly include Qure.ai, HeartFlow and AIdoc. Here is the list of Top 10 competitors of Cleerly, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Qure.ai 2016, Mumbai (India), Series D	Developer of artificial intelligence software for medical imaging diagnostic analysis	$123M	HealthQuad, 360 One & 48 others	74/100
2nd	HeartFlow 2007, Redwood City (United States), Public	Provides cardiovascular diagnostic support using analytics	$936M	Bain Capital Life Sciences, Baillie Gifford ... & 24 others	70/100
3rd	AIdoc 2016, New York City (United States), Series E	Developer of clinical AI solutions for healthcare imaging and patient management	$534M	AIC, General Catalyst & 35 others	69/100
4th	Oxipit 2017, Vilnius (Lithuania), Acquired	Developer of medical imaging software for automated radiology diagnostic support	$6.69M	Practica Capital, CoInvest Capital & 4 others	66/100
5th	Subtle Medical 2017, Palo Alto (United States), Series C	AI-driven solutions for medical diagnostic imaging	$86M	Morgan Stanley, 3E Bioventures Capital & 27 others	66/100
6th	Gleamer 2017, Paris (France), Acquired	Developer of artificial intelligence software for medical imaging diagnostic analysis	$40M	Elaia, XAnge & 11 others	65/100
7th	ScreenPoint 2014, Nijmegen (Netherlands), Series C	Developer of artificial intelligence software for analyzing breast imaging mammograms	$47M	Siemens, Insight Partners & 3 others	64/100
8th	Brainomix 2010, Oxford (United Kingdom), Series C	Developer of automated medical imaging software for stroke and lung	$63.3M	Parkwalk, IP Group Hostplus Innovation Fund ... & 16 others	63/100
9th	Cleerly 2016, Denver (United States), Series C	Provider of an AI-driven platform for coronary artery disease assessment	$578M	T. Rowe Price, Fidelity Investments & 20 others	63/100
10th	Carpl 2018, Cupertino (United States), Series A	Provider of an enterprise imaging platform that streamlines radiology workflows through a unified marketplace of artificial intelligence applications	$16M	IFC, Stellaris Venture Partners & 2 others	63/100